UBS today maintained a Buy rating on Express Scripts (NASDAQ: ESRX) and raised its price target to $69.00 (from $66.00).
This article: 115 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE